1. Home
  2. OFIX vs DNA Comparison

OFIX vs DNA Comparison

Compare OFIX & DNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Orthofix Medical Inc. (DE)

OFIX

Orthofix Medical Inc. (DE)

HOLD

Current Price

$12.86

Market Cap

473.3M

Sector

Health Care

ML Signal

HOLD

Logo Ginkgo Bioworks Holdings Inc.

DNA

Ginkgo Bioworks Holdings Inc.

HOLD

Current Price

$7.79

Market Cap

455.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OFIX
DNA
Founded
1987
2008
Country
United States
United States
Employees
N/A
485
Industry
Medical/Dental Instruments
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
473.3M
455.8M
IPO Year
1998
N/A

Fundamental Metrics

Financial Performance
Metric
OFIX
DNA
Price
$12.86
$7.79
Analyst Decision
Buy
Hold
Analyst Count
5
2
Target Price
$17.25
$8.50
AVG Volume (30 Days)
228.9K
1.1M
Earning Date
05-05-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
29.39
N/A
EPS
N/A
N/A
Revenue
$822,312,000.00
N/A
Revenue This Year
$6.10
N/A
Revenue Next Year
$6.24
N/A
P/E Ratio
N/A
N/A
Revenue Growth
2.85
N/A
52 Week Low
$10.25
$5.37
52 Week High
$16.99
$17.58

Technical Indicators

Market Signals
Indicator
OFIX
DNA
Relative Strength Index (RSI) 61.64 58.83
Support Level $12.33 $6.26
Resistance Level $16.38 $10.06
Average True Range (ATR) 0.41 0.58
MACD 0.19 0.19
Stochastic Oscillator 88.71 91.80

Price Performance

Historical Comparison
OFIX
DNA

About OFIX Orthofix Medical Inc. (DE)

Orthofix Medical Inc. is a medical device company delivering orthopedic and spine solutions to healthcare providers. The company has two reportable segments: Global Spine and Global Limb Reconstruction. The Global Spine segment offers bone growth therapies, spinal implants, biologics, and enabling technologies used in spinal procedures. The Global Limb Reconstruction segment provides products and solutions for limb deformity correction, limb lengthening, fracture management, and limb preservation, supported by digital technologies. It generates the majority of its revenue from the Global Spine segment.

About DNA Ginkgo Bioworks Holdings Inc.

Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering engaged in providing biological R&D services for customers across a range of industries and Biosecurity that provides services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.

Share on Social Networks: